Bruker’s benchtop NMR system combines the company's experience and longevity in the systems market with the cutting-edge technology of nuclear magnetic resonance (NMR) to create the most accurate and ...

BILLERICA, Mass.--(BUSINESS WIRE)--Bruker Corporation (Nasdaq: BRKR) today announced the successful installation and customer acceptance of the Avance™ NEO 1.2 GHz NMR system at the Department of ...

BILLERICA, Mass.--(BUSINESS WIRE)--Bruker Corporation (Nasdaq: BRKR) today announced the successful installation and customer acceptance of the world’s first Avance™ NEO 1.2 GHz NMR system at the CERM ...

Elevate the analytical capabilities and enhance the curriculum with a high-performance NMR in a compact, user-friendly benchtop system. This tool is designed to help the user overcome challenges and ...

Bruker Corporation (NASDAQ:BRKR) ranks among the best medical device stocks to invest in. Bruker Corporation (NASDAQ:BRKR) ...

Bruker Corporation BRKR has introduced an innovative Fourier 80 multinuclear benchtop FT-Nuclear Magnetic Resonance (NMR) spectrometer, known as the ‘Multi-Talent’ configuration. Unveiled at the Joint ...

Bruker Corporation BRKR recently announced the successful installation and acceptance of a 1.2 GHz Avance Nuclear Magnetic Resonance (“NMR”) spectrometer at the Korea Basic Science Institute (“KBSI”).

The New York Structural Biology Center (NYSBC) ordered an NIH-funded Multifield NMR Relaxometry System. This advanced relaxometry system will be the first in North America and serves a consortium of ...

Thanks to the tireless efforts and support by our customers and partners at CERM, as well as by our field service engineers, Bruker was able to carry out this first ultra-high field NMR 1.2 GHz ...